Innovating Works

MAASTRO

Desconocido
PRE-ACT: PRE ACT Prediction of Radiotherapy side Effects using explainable AI for patient Communication and... STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Radiotherapy is a widely used cancer treatment, however some patients suffer side effects. In breast cancer, side effects can include breast...
2022-05-23 - 2027-09-30 | Financiado
PROTECT-trial: Proton versus Photon Therapy for Esophageal Cancer a Trimodality Strategy STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage The aim of PROTECT-trial is to compare the clinical outcome of proton therapy (PT) and conventional radiotherapy in a randomized study and t...
2021-07-07 - 2027-06-30 | Financiado
STOPSTORM: A PROSPECTIVE EUROPEAN VALIDATION COHORT FOR STEREOTACTIC THERAPY OF RE ENTRANT TACHYCARDIA STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un H2020: H2020-SC1-BHC-2018-2020 Ventricular tachycardia (VT) is an unpredictable and potentially deadly condition and should be promptly treated with catheter ablation and...
2021-01-21 - 2027-04-30 | Financiado
BD2Decide: Big Data and models for personalized Head and Neck Cancer Decision support STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un H2020: H2020-PHC-2014-2015 "Cancers of the Head and Neck Region (HNC) are the 6th more deadly cancers worldwide: in Europe ~150.000 new cases are detected and ~70.000...
2015-11-11 - 2019-09-30 | Financiado
QUIC-CONCEPT: QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP6: The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proli...
2011-09-01 - 2018-06-30 | Financiado
STERRPA: Development of a Spatio Temporal Energetic Radiation Research Platform for Animals STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC tramitó un FP7: In modern radiotherapy complex radiation fields are applied on cancer patients to eradicate cancer cells, while sparing the surrounding heal...
Financiado
LOGX: Low Energy Gamma and X ray therapy STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC tramitó un FP7: Cancer is a serious disease with high mortality and morbidity. Treatment is often performed with radiation therapy. To assure a good control...
Financiado
ARTFORCE: Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: Loco-regional treatment is the mainstay of cancer cures in non small lung and head and neck cancer. For advanced stage cancer, dose intense...
Financiado
ENVISION: European NoVel Imaging Systems for ION therapy STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: Following the pioneering experiences which lasted several decades, particle therapy has become a recognized way of curing cancer. 2 new Euro...
Financiado
REQUITE: Validating predictive models of radiotherapy toxicity to improve quality of life and reduce side eff... STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: Long-term side-effects of radiotherapy impact on the quality-of-life (QoL) of cancer survivors. These side-effects could be reduced if predi...
Financiado
METOXIA: Metastatic tumours facilitated by hypoxic tumour micro environments STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermo...
Financiado
EURECA: Enabling information re Use by linking clinical REsearch and CAre STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: EURECA aims to build an advanced, standards-based and scalable semantic integration environment enabling seamless, secure and consistent bi-...
Financiado
QUIC-CONCEPT: QUantitative Imaging in Cancer CONnecting CEllular Processes with Therapy STICHTING MAASTRICHT RADIATION ONCOLOGY MAASTRO CLINIC participó en un FP7: The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell prol...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.